MSD wins FDA priority review for Welireg in rare endocrine cancer
If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.
If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.
What's Your Reaction?
